This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Jun 15;109(12):2387-91.

doi: 10.1002/cncr.22711.

Moving forward with breast cancer prevention

Wendy Y Chen¹, Bernard Rosner, Graham A Colditz

Affiliations

Affiliation

¹ Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. wendy.chen@channing.harvard.edu

PMID: 17464950
DOI: 10.1002/cncr.22711

Free article

Review

Moving forward with breast cancer prevention

Wendy Y Chen et al. Cancer. 2007.

Free article

. 2007 Jun 15;109(12):2387-91.

doi: 10.1002/cncr.22711.

Authors

Wendy Y Chen¹, Bernard Rosner, Graham A Colditz

Affiliation

¹ Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. wendy.chen@channing.harvard.edu

PMID: 17464950
DOI: 10.1002/cncr.22711

No abstract available

PubMed Disclaimer

Similar articles

Selective estrogen-receptor modulators for primary prevention of breast cancer.
Fabian CJ, Kimler BF. Fabian CJ, et al. J Clin Oncol. 2005 Mar 10;23(8):1644-55. doi: 10.1200/JCO.2005.11.005. J Clin Oncol. 2005. PMID: 15755972 Review. No abstract available.
Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
[No authors listed] [No authors listed] Harv Womens Health Watch. 2002 Oct;10(2):1-2. Harv Womens Health Watch. 2002. PMID: 12393316 No abstract available.
Raloxifene (Evista) for breast cancer prevention in postmenopausal women.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2006 May 8;48(1234):37. Med Lett Drugs Ther. 2006. PMID: 16685245
Drugs can reduce the incidence of breast cancer: now what?
Wozniak TF, Eppes PG, Wilson CT. Wozniak TF, et al. Del Med J. 1999 Sep;71(9):387-9. Del Med J. 1999. PMID: 10584440 Clinical Trial. No abstract available.
Breast cancer risk reduction: what do we know and where should we go?
Prout MN. Prout MN. Medscape Womens Health. 2000 Sep-Oct;5(5):E4. Medscape Womens Health. 2000. PMID: 11113777 Review.

See all similar articles

Cited by

Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality.
Colditz GA, Wei EK. Colditz GA, et al. Annu Rev Public Health. 2012 Apr;33:137-56. doi: 10.1146/annurev-publhealth-031811-124627. Epub 2012 Jan 3. Annu Rev Public Health. 2012. PMID: 22224878 Free PMC article. Review.
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.
Rohan TE, Negassa A, Chlebowski RT, Ceria-Ulep CD, Cochrane BB, Lane DS, Ginsberg M, Wassertheil-Smoller S, Page DL. Rohan TE, et al. Breast Cancer Res Treat. 2009 Jul;116(2):339-50. doi: 10.1007/s10549-008-0213-0. Epub 2008 Oct 14. Breast Cancer Res Treat. 2009. PMID: 18853250 Free PMC article. Clinical Trial.
Suitable trial designs and cohorts for preventive breast cancer agents.
Strasser-Weippl K, Goss PE. Strasser-Weippl K, et al. Nat Rev Clin Oncol. 2013 Dec;10(12):677-87. doi: 10.1038/nrclinonc.2013.174. Epub 2013 Oct 8. Nat Rev Clin Oncol. 2013. PMID: 24101120 Review.
Applying what we know to accelerate cancer prevention.
Colditz GA, Wolin KY, Gehlert S. Colditz GA, et al. Sci Transl Med. 2012 Mar 28;4(127):127rv4. doi: 10.1126/scitranslmed.3003218. Sci Transl Med. 2012. PMID: 22461645 Free PMC article. Review.
Prevention trials: their place in how we understand the value of prevention strategies.
Colditz GA, Taylor PR. Colditz GA, et al. Annu Rev Public Health. 2010;31:105-20. doi: 10.1146/annurev.publhealth.121208.131051. Annu Rev Public Health. 2010. PMID: 20070190 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

P01 CA 087969/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information